Salim Yazji
Technik-/Wissenschafts-/F&E-Leiter bei ONCTERNAL THERAPEUTICS, INC.
Vermögen: 53 056 $ am 30.04.2024
Aktive Positionen von Salim Yazji
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONCTERNAL THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.05.2021 | - |
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Direktor/Vorstandsmitglied | 01.04.2019 | - |
Elpida Therapeutics | Gründer | - | - |
Karriereverlauf von Salim Yazji
Ehemalige bekannte Positionen von Salim Yazji
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BAXALTA INC | Corporate Officer/Principal | - | - |
PMV PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ajuta Therapeutics, Inc. | Vorstandsvorsitzender | - | - |
Gründer | - | - |
Ausbildung von Salim Yazji
Pavlov First Saint Petersburg State Medical University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Russland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Founder | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PMV PHARMACEUTICALS, INC. | Commercial Services |
ONCTERNAL THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ. | Health Technology |
Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc. BiotechnologyHealth Technology Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017. | Health Technology |
Ajuta Therapeutics, Inc. | |
Elpida Therapeutics |
- Börse
- Insiders
- Salim Yazji
- Erfahrung